Solid Biosciences Inc. SEC filings SLDB

Solid Biosciences Inc. has 737 filings in SEC EDGAR's recent list, going back to Aug 4, 2017. Its latest annual report, Form ARS, was filed on Apr 23, 2026 for the period ended Dec 31, 2025. The latest quarterly report (Form 10-Q) was filed on Nov 4, 2026, covering the quarter ended Sep 30, 2026. The most recent current report (Form 8-K) was filed on Aug 6, 2026 (other events). The company's fiscal year ends on December 31.

Form Description Filed Period
ARS Annual report to shareholders Apr 23, 2026 Dec 31, 2025
10-K Annual report Mar 19, 2026 Dec 31, 2025
ARS Annual report to shareholders Apr 25, 2025 Dec 31, 2024
10-K Annual report Mar 6, 2025 Dec 31, 2024
ARS Annual report to shareholders Apr 26, 2024 Dec 31, 2023
10-K Annual report Mar 13, 2024 Dec 31, 2023
ARS Annual report to shareholders Apr 27, 2023 Dec 31, 2022
10-K Annual report Mar 23, 2023 Dec 31, 2022
10-K Annual report Mar 14, 2022 Dec 31, 2021
10-K Annual report Mar 15, 2021 Dec 31, 2020
10-K/A Amended annual report Mar 13, 2020 Dec 31, 2019
10-K Annual report Mar 12, 2020 Dec 31, 2019
10-K Annual report Mar 13, 2019 Dec 31, 2018
10-K Annual report Mar 29, 2018 Dec 31, 2017

Showing 14 filings. Main filings leave out insider and ownership forms such as Form 4; choose a type above to see them. Each form opens on SEC.gov. Older filings are on SEC EDGAR.

New to this? Read What Are SEC Filings? 10-K, 10-Q, 8-K and Other Forms Explained.

Company profile

Industry
Biological Products, (No Diagnostic Substances) (SIC 2836)
Listed as
SLDB (Nasdaq)
Fiscal year ends
December 31
Incorporated in
DE
Headquarters
Charlestown, MA
SEC filer status
Non-accelerated filer, Smaller reporting company
SEC CIK
1707502
Former names
Solid Biosciences, LLC (until Jan 25, 2018)

Other Biological Products, (No Diagnostic Substances) companies

All 182 Biological Products, (No Diagnostic Substances) companies

Source: SEC EDGAR filings. This is company-reported data, not investment advice.